Can you tell a Perfect Enemy? | Page 328 | theperfectenemy.com
September 17, 2025

Bavarian Nordic’s COVID-19 Booster Vaccine Candidate Demonstrates Durable Antibody Response Six Months After Vaccination in Phase 2 Clinical Trial

Bavarian Nordic A/SCOPENHAGEN, Denmark, October 17, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today the results of a six-month...

GeNeuro: Presentation at the International Society of NeuroVirology 2022 of Top-Line Data of Academic Collaborations Further Documenting the Long-Term Expression of the Proinflammatory and Neuropathogenic W-ENV Protein in Cohorts of Post-COVID…